199 Biotechnologies

199 Biotechnologies aims to revolutionise the healthcare model by creating cutting-edge technologies that mimic Nature's design processes. Their computational platform integrates physics-based modelling, deep learning, and high-performance computing to navigate the vast landscape of protein sequence and structure space. The company focuses on designing novel proteins for therapeutics (e.g., biologics, vaccines) and diagnostics (e.g., biosensors, enzymes), endeavouring to expedite the integration of these innovations into commercial products through strategic clinical partnerships.